Divis Laboratories Fact Sheet, Divis Laboratories Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Divis Laboratories Fact Sheet    (DIVI)

Here is the latest financial fact sheet of Divis Laboratories. For more details, see the Divis Laboratories quarterly results and Divis Laboratories share price and chart. For a sector overview, read our pharmaceuticals sector report.

DIVIS LABORATORIES Price History

Price Rs 1,735.0
Mkt Cap Rs m 460,574
Vol '000 6.4
P/E X 34.5
P/CF X 30.3
EPS (TTM) Rs 50.2
% ch % -0.4
No. of shares m 265.47
% ch week % 0.8
% ch 1-mth % 7.7
% ch 12-mth % 38.8
52 week H/L Rs 1,771.7/1,214.3
(As on Oct 23, 2019 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

DIVIS LABORATORIES Financials

No. of Mths
Year Ending
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
5-Yr Chart
Click to enlarge
DIVIS LABORATORIES EQUITY SHARE DATA
High Rs1,8812,4841,2221,1421,639 
Low Rs1,2179187845331,115 
Sales per share (Unadj.) Rs234.7142.3153.1146.6186.3 
Earnings per share (Unadj.) Rs64.242.439.933.051.0 
Diluted earnings per shareRs32.142.439.933.051.0 
Cash flow per share (Unadj.) Rs74.446.944.638.457.3 
Dividends per share (Unadj.) Rs20.0010.0010.0010.0016.00 
Adj. dividends per shareRs10.0010.0010.0010.0016.00 
Dividend yield (eoy) %1.30.61.01.21.2 
Book value per share (Unadj.) Rs288.0161.7201.8222.8261.8 
Adj. book value per shareRs144.0161.7201.8222.8261.8 
Shares outstanding (eoy) m132.73265.47265.47265.47265.47 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x6.612.06.65.77.4 
Avg P/E ratio x24.140.125.125.327.0 
P/CF ratio (eoy) x20.836.322.521.824.0 
Price / Book Value ratio x5.410.55.03.85.3 
Dividend payout %31.223.625.030.331.4 
Avg Mkt Cap Rs m205,599451,525266,266222,318365,592 
No. of employees `0008.79.59.710.811.8 
Total wages/salary Rs m2,9043,6124,9994,5615,423 
Avg. sales/employee Rs Th3,571.83,983.14,175.03,616.04,175.1 
Avg. wages/employee Rs Th333.0381.0513.5423.8457.7 
Avg. net profit/employee Rs Th976.41,187.41,089.3814.91,141.8 
DIVIS LABORATORIES INCOME DATA
Net Sales Rs m31,14937,76440,64338,91549,463 
Other income Rs m4479747491,1341,556 
Total revenues Rs m31,59638,73841,39240,04951,019 
Gross profit Rs m11,65214,17414,46012,61718,718 
Depreciation Rs m1,3601,1821,2331,4251,689 
Interest Rs m1938231335 
Profit before tax Rs m10,72113,92813,95312,31318,551 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m2,2062,6713,3493,5435,023 
Profit after tax Rs m8,51511,25810,6048,77013,527 
Gross profit margin %37.437.535.632.437.8 
Effective tax rate %20.619.224.028.827.1 
Net profit margin %27.329.826.122.527.3 
DIVIS LABORATORIES BALANCE SHEET DATA
Current assets Rs m27,72430,27040,10545,35146,501 
Current liabilities Rs m4,5605,1956,5956,5348,468 
Net working cap to sales %74.466.482.599.776.9 
Current ratio x6.15.86.16.95.5 
Inventory Days Days136117119127131 
Debtors Days Days8785819586 
Net fixed assets Rs m15,23116,99819,99521,16025,797 
Share capital Rs m266531531531531 
"Free" reserves Rs m37,95842,40253,04358,62568,962 
Net worth Rs m38,22342,93353,57459,15669,493 
Long term debt Rs m115000 
Total assets Rs m43,82949,02161,58567,85980,383 
Interest coverage x577.4369.5618.4926.8531.0 
Debt to equity ratio x00000 
Sales to assets ratio x0.70.80.70.60.6 
Return on assets %19.523.017.312.916.9 
Return on equity %22.326.219.814.819.5 
Return on capital %28.132.526.120.826.7 
Exports to sales %84.385.3000 
Imports to sales %23.922.925.221.824.6 
Exports (fob) Rs m26,24432,198000 
Imports (cif) Rs m7,4428,65410,2608,48512,187 
Fx inflow Rs m26,31732,27035,38432,35941,238 
Fx outflow Rs m7,5888,77510,3999,04212,405 
Net fx Rs m18,72923,49624,98523,31728,833 
DIVIS LABORATORIES CASH FLOW
From Operations Rs m 8,263 10,379 11,504 7,759 9,543 
From Investments Rs m -5,208 -4,064 -11,396 -4,783 -6,854 
From Financial Activity Rs m -3,030 -6,311 24 -3,142 -2,459 
Net Cashflow Rs m 25 3 132 -166 230 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 52.0%
Foreign collaborators 0.0%
Indian inst/Mut Fund 11.8%
FIIs 19.0%
ADR/GDR 0.0%
Free float 17.2%
Shareholders 31,796
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 7-1-77/E/1/303, Divi Towers, Dharam Karan Road, Ameerpet, Hyderabad-16
E-MAIL cs@divislaboratories.com WEB www.divislaboratories.com
TELEPHONE (040) 2378 6300 FAX (040) 2378 6460
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR P. V. R. K. Nageswara Rao & Co.
CHM: Murali K. Divi (MD) COMP SEC: P. V. Lakshmi Rajani YEAR OF INC: 1990 BSE CODE: 532488 FV (Rs): 2 DIV YIELD (%): 0.9

Read: DIVIS LABORATORIES 2018-19 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   BIOCON   AMAR REMEDIES  TTK HEALTHCARE  ELDER PHARMA  ALKEM LABORATORIES  

Compare DIVIS LABORATORIES With:   BIOCON   AMAR REMEDIES  TTK HEALTHCARE  ELDER PHARMA  ALKEM LABORATORIES  

Compare DIVIS LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

September Quarter Results, IPO Buzz, and Top Stocks in Action Today(Pre-Open)

On Wednesday, Indian share markets traded rangebound throughout the day and ended marginally higher. The BSE Sensex closed higher by 95 points to end above 39,000-mark.

Views on news

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

DIVIS LABORATORIES Announces Quarterly Results (1QFY20); Net Profit Up 0.4% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 0.4% YoY). Sales on the other hand came in at Rs 11 bn (up 14.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY19); Net Profit Up 10.6% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, DIVIS LABORATORIES has posted a net profit of Rs 3 bn (up 10.6% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

My Top 10 Stocks for Accelerated Profits

Oct 18, 2019

Equitymaster's co-head of research and editor of Microcap Millionaires, Rahul Shah, talks to us about his market-beating system and his 10 best stocks to buy now. Listen in...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES - PFIZER COMPARISON

COMPARE DIVIS LABORATORIES WITH

MARKET STATS